Anandamide

What it isThe first endocannabinoid identified, a CB1 partial agonist degraded by FAAH.

Why this oneIts partial agonism is why endogenous cannabinoid signaling is subtler than THC’s full agonism.

What limits itFAAH inhibitors raise it selectively where it is already being made, which is why they were expected to avoid intoxication.